Skip to main content
Premium Trial:

Request an Annual Quote

Golden Helix, CloudScientific Ink Chinese Distribution Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Golden Helix today announced that it has entered into a deal in which CloudScientific will distribute the company's analytical services and SNP & Variation Suite software in China.

Terms of the deal were not disclosed.

In a statement, officials from both firms noted the "explosive growth" in genetic research in China, and Andrew Ferrin, executive vice president of business development for Golden Helix, said that his firm has more inquiries from customers in China than any other country, aside from the US and Canada.

Jack Lin, CEO of CloudScientific, added, "Our partnership with Golden Helix will enable CloudScientific to further serve this market, providing exceptional analytical capabilities for genetic research."

CloudScientific is a Chinese firm that offers life science software programs and solutions.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.